...
首页> 外文期刊>Oncology reports >Broussonetia kazinoki modulates the expression of VEGFR-2 and MMP-2 through the inhibition of ERK, Akt and p70(S6K)-dependent signaling pathways: Its implication in endothelial cell proliferation, migration and tubular formation
【24h】

Broussonetia kazinoki modulates the expression of VEGFR-2 and MMP-2 through the inhibition of ERK, Akt and p70(S6K)-dependent signaling pathways: Its implication in endothelial cell proliferation, migration and tubular formation

机译:假单胞菌通过抑制ERK,Akt和p70(S6K)依赖性信号通路来调节VEGFR-2和MMP-2的表达:提示其对内皮细胞增殖,迁移和肾小管形成的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Broussonetia kazinoki (BK) has been used as a traditional medicine to improve vision, as well as for inflammatory and infectious diseases. In the present study, we investigated the effects and molecular mechanism of the ethanolic extract of BK on cell proliferation, migration and tubular formation in vascular endothelial growth factor-A (VEGF-A)treated human umbilical vein endothelial cells. BK treatment inhibited VEGF-A-stimulated endothelial cell proliferation through the downregulation of cell cycle-related proteins including cyclin-dependent kinases and cyclins. Moreover, BK treatment suppressed cell migration and tubular formation in response to VEGF-A. These anti-angiogenic activities of BK were associated with the inactivation of mitogenic signaling pathways including extracellular signal-regulated kinase, Akt and p70(S6K), and the subsequent downregulation of VEGFR-2 and matrix metalloproteinase-2. Taken together, these findings suggest further evaluation and development of BK as a potential therapeutic agent for the treatment and prevention of angiogenesis-related diseases including cancer.
机译:鸡爪草(Broussonetia kazinoki)(BK)已被用作改善视力以及发炎和感染性疾病的传统药物。在本研究中,我们研究了BK乙醇提取物对血管内皮生长因子-A(VEGF-A)处理的人脐静脉内皮细胞增殖,迁移和肾小管形成的影响及其分子机制。 BK治疗通过下调细胞周期相关蛋白(包括细胞周期蛋白依赖性激酶和细胞周期蛋白)来抑制VEGF-A刺激的内皮细胞增殖。此外,BK处理可抑制细胞迁移和对VEGF-A的肾小管形成。 BK的这些抗血管生成活性与细胞外信号调节激酶,Akt和p70(S6K)的促有丝分裂信号通路的失活以及随后的VEGFR-2和基质金属蛋白酶2的下调有关。综上所述,这些发现暗示了对BK的进一步评估和开发,BK作为治疗和预防与血管生成有关的疾病(包括癌症)的潜在治疗剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号